Boston Scientific Corporation Stock price
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.24 USD | +1.52% | +1.69% | +16.31% |
Financials (USD)
Sales 2024 * | 15.56B | Sales 2025 * | 16.99B | Capitalization | 98.65B |
---|---|---|---|---|---|
Net income 2024 * | 2.06B | Net income 2025 * | 2.58B | EV / Sales 2024 * | 6.71 x |
Net Debt 2024 * | 5.69B | Net Debt 2025 * | 2.55B | EV / Sales 2025 * | 5.95 x |
P/E ratio 2024 * |
48.4
x | P/E ratio 2025 * |
39.6
x | Employees | 48,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.46% |
Latest transcript on Boston Scientific Corporation
1 day | +1.52% | ||
1 week | +1.69% | ||
Current month | +1.56% | ||
1 month | +2.16% | ||
3 months | +21.13% | ||
6 months | +26.87% | ||
Current year | +16.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 59 | 11-10-16 |
Daniel Brennan
DFI | Director of Finance/CFO | 58 | 96-11-30 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 09-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Wichmann
BRD | Director/Board Member | 61 | 21-06-22 |
Director/Board Member | 69 | 15-03-31 | |
Edward Ludwig
BRD | Director/Board Member | 72 | 14-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.26% | 12 M€ | +15.09% | - | |
1.98% | 1 M€ | +2.21% | - | |
1.75% | 18 M€ | +5.16% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 67.24 | +1.52% | 5,833,683 |
24-03-15 | 66.23 | -0.94% | 8,850,950 |
24-03-14 | 66.86 | +1.24% | 7,327,729 |
24-03-13 | 66.04 | -2.15% | 9,236,134 |
24-03-12 | 67.49 | +2.07% | 6,462,540 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.31% | 98.65B | |
+9.28% | 221B | |
+8.70% | 186B | |
+16.38% | 139B | |
+5.51% | 67.33B | |
+21.77% | 55.83B | |
+0.85% | 49.24B | |
+5.08% | 42.81B | |
+17.19% | 41.26B | |
+11.01% | 28.05B |